Phil Tennant sold $594k of PGEN
Chief Commercial Officer at PRECIGEN, INC.. 79,166 shares at an average of $7.50, traded Aug 25, 2026, filed Aug 25, 2026.
Score components
- +15RoleOfficer
- +19Trade size$594k at market
- +10Share of holdings soldSold 36% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950103-26-012871, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 23, 2026 | MOption exercise Common Stock10b5-1 | +5,208 | - | - | 144,577 | Aug 25, 2026 |
| Aug 23, 2026 | FTax withholding Common Stock10b5-1 | -2,585 | $7.20 | $19k | 141,992 | Aug 25, 2026 |
| Aug 25, 2026 | MOption exercise Common Stock10b5-1 | +79,166 | $1.61 | $127k | 221,158 | Aug 25, 2026 |
| Aug 25, 2026 | SOpen-market sale Common Stock10b5-1 | -79,166 | $7.50 | $594k | 141,992 | Aug 25, 2026 |
| Aug 23, 2026 | MOption exercise Restricted Stock Unitsderivative10b5-1 | -5,208 | $0.00 | $0 | 57,292 | Aug 25, 2026 |
| Aug 25, 2026 | MOption exercise Option to Purchase Common Stock (Right to Buy)derivative10b5-1 | -79,166 | $0.00 | $0 | 120,834 | Aug 25, 2026 |
Related signals
Other insiders at PRECIGEN, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 75Notable | PRECIGEN, INC. | Jeffrey B Kindler director | $1.4M 185,000 shares | -92% | |
| 15Weak | PGENbuy PRECIGEN, INC. | Nancy H Agee director | $25k 3,411 shares | +1% | |
| 21Weak | PRECIGEN, INC. | Rutul R Shah Chief Operating Officer | $375k 50,000 shares | -10% | |
| 20Weak | PRECIGEN, INC. | Rutul R Shah Chief Operating Officer | $225k 32,739 shares | -7% | |
| 5Weak | PRECIGEN, INC. | Rutul R Shah Chief Operating Officer | $220k 33,772 shares | -6% | |
| 39Weak | PRECIGEN, INC. | Harry Thomasian Jr. Chief Financial Officer | $606k 100,000 shares | -28% | |
| 30Weak | PRECIGEN, INC. | Helen Sabzevari President and CEO | $2.0M 346,836 shares | -8% | |
| 13Weak | PRECIGEN, INC. | Rutul R Shah Chief Operating Officer | $251k 42,924 shares | -8% | |
| 52Moderate | PRECIGEN, INC. | Harry Thomasian Jr. Chief Financial Officer | $1.1M 200,000 shares | -36% | |
| 41Moderate | PRECIGEN, INC. | Donald P. Lehr Chief Legal Officer | $127k 29,131 shares | -4% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.